| Literature DB >> 23275603 |
Sergio Occhipinti1, Chiara Dianzani, Annalisa Chiocchetti, Elena Boggio, Nausicaa Clemente, Casimiro Luca Gigliotti, Maria Felicia Soluri, Rosalba Minelli, Roberto Fantozzi, Jungi Yagi, Josè Maria Rojo, Daniele Sblattero, Mirella Giovarelli, Umberto Dianzani.
Abstract
B7h, expressed by several cell types, binds ICOS expressed by activated T cells. We have previously shown that B7h triggering by ICOS-Fc inhibits human endothelial cell adhesiveness. This work investigated the effect of ICOS-Fc on human monocyte-derived dendritic cells (DCs). We found that DCs matured with LPS in the presence of ICOS-Fc (mDCs(ICOS)) produced greater amounts of IL-23 and IL-10, and promoted a higher secretion of IL-17A and IL-17F in MLCs than did those DCs matured with LPS alone (mDCs). Moreover, mDCs(ICOS) pulsed with the keyhole limpet hemocyanin Ag during the maturation phase were better stimulators of Ag-specific MHC class I-, but not class II-restricted T cells than mDCs. This was probably due to promotion of cross-presentation because it was not detected when the Flu-MA(58-66) Ag was directly loaded on already matured DCs and mDCs(ICOS). Finally, ICOS-Fc inhibited the adhesion of both immature DCs and mDCs to vascular and lymphoid endothelial cells, their migratory activity, and the expression of the Rac-1 activator β-Pix involved in cell motility. These data suggest that B7h stimulation modulates DC function with effects on their maturation and recruitment into tissues. This opens a novel view on the use of interactors of the ICOS:B7h system as immunomodulatory drugs.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23275603 DOI: 10.4049/jimmunol.1201816
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422